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Abstract 
Mucins are heavily glycosylated epithelial proteins. Under or overexpression of 
mucins may lead to several different types of dysfunctions. Mucins are under 
investigation as possible diagnostic markers for malignancies and other disease. This 
study examined the over/under expression of Mucin-3 in the presence of IP6. Three 
groups of six mice were fed varying levels of phytate (inositol 6-phosphate, IP6) for six 
days before being subjected to carbon dioxide asphyxiation. Sections of the duodenum, 
jejunum, ileum, stomach, and colon were collected, lysed, and the tissue proteins were 
prepared and analyzed by Western Blot to determine Mucin-3 expression. The hypothesis 
was that the presence of phytate in the digestive tract would modulate the expression of 
Mucin 3. Results showed that on average, Mucin 3 expression in untreated tissue was 
higher in areas of the duodenum and jejunum and lower in the ileum and stomach. 
Presence of IP6 decreased expression of Mucin 3 in the stomach by one percent in the 
1g/kg phytate group while increasing in the 2g/kg phytate group by one percent. The 
expression of Mucin 3 in the duodenum increased fifty-five and thirty-nine percent in the 
1g/kg and 2g/kg phytate groups, respectively. Jejunum Mucin 3 expression was increased 
by ninety percent in both 1g/kg and 2g/kg phytate groups. The ileum 0g/kg and 2g/kg 
phytate groups had the same expression of Mucin 3, but the 1g/kg group had a thirty-six 
percent decrease. 
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Introduction 
Mechanism of Cancer and Anti-Cancerous Compounds 
There has been a long search for compounds that can prevent cancers or inhibit 
the occurrence of certain cancers. Cancer generally arises through mutations in either 
stem or progenitor cells or mutations that alter a differential cell (Keyes, 2013). Most of 
the protective components of the cell include stimulatory (proto-oncogene) and inhibitory 
(tumor inhibition) components (Keyes, 2013). Cancer mechanisms include a signaling 
pathway that is specific for each gene. Alteration of this pathway allows cells to 
proliferate and multiply indefinitely (Keyes, 2013).  A single oncogene is not sufficient to 
give rise to cancer, but over time, interactions between the environment and other 
proliferations give rise to more mutations (Keyes, 2013). Multiple molecular 
mechanisms, both intrinsic and extrinsic, converge to alter core cellular metabolism and 
provide support for the three basic needs of dividing cells: rapid ATP generation to 
maintain energy status; increased biosynthesis of macromolecules; and tightened 
maintenance of appropriate cellular redox status (Cairns, 2011). Mutations can alter the 
cell cycle checkpoints of the cell, which could lead to cancer. It is now clear that there are 
thousands of point mutations, translocations, amplifications and deletions that may 
contribute to cancer development, and that the mutational range can differ even among 
similar tumors (Cairns, 2011). 
The cancer critical genes are often ultimately at the molecular level in the mitotic 
cell cycle at different checkpoints (G1, G2, and spindle assembly checkpoint) (Alberts, 
2002). The G1 checkpoint checks for DNA damage, cell size, and growth factors. The G2 
checkpoint also checks for cell size, and DNA replication. Alterations in these 
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checkpoints can lead to apoptosis, programmed cell death, which is critical for the cell to 
function properly (Alberts, 2002). Protein p53 is one of the proteins that control this 
critical function (Alberts, 2002). 
 
Inositol Phosphates 
Inositol 6-phosphate (IP6) or “phytate” is a compound found in starchy foods 
such as beans, cereal, nuts, legumes, pollen, and spores (Graf, 1990). The ability of 
phytic acid to complex with proteins and minerals has been a subject of investigation 
from chemical as well as nutritional standpoints (Urbano, 2000). Phytate is converted into 
compounds in the body that are used by cells to relay outside messages to the cell nucleus 
as well as aids in the catabolism of calcium and other minerals (Basic, 2010). Phytate as 
well as other inositol phosphates are abundant in mammalian cells (Singh, 2008). 
Inositol phosophates function as second messengers for a variety of cell signaling 
mechanisms. Phosphorylation and dephosporylation of inositol phosphates are an 
important intracellular event of signal transduction in a variety of tissues (Yang, 1995). 
Second messengers are molecules that allow individual cells within the organism to 
respond to signals generated outside of the cell. An example would be plants in the field 
that respond to a variety of signals such as drought, pests and pathogens. Inositol 
phosphates have many defined roles in regulation in the cell. IP1 to IP5 are recognized as 
intracellular messengers. A second messenger role of inositol 1,4,5-trisphosphate is 
bringing about a host of cellular functions including mitosis via mobilizing intracellular 
Ca2+ is well recognized (Shamshuddin, 1995). Ca2+ sequestration is key function of 
1,3,4,5-tetrakisphosphate (Shamshuddin, 1995).  
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Inositol 6-Phosphate 
Both in vivo and in vitro experiments have demonstrated striking anticancer 
(preventive as well as therapeutic) effects of IP6 (Shamshuddin, 2002). Inositol 6- 
phosphate is a six-carbon sugar with six hydroxyl groups (inositol) that are 
phosphorylated (Shamsuddin, 2002). Inositol phosphates, including phytate play a critical 
role in neurotransmission (Shears, 1996), regulation of vesicle trafficking and recycling 
(Shears, 1996), and endocytosis and exocytosis (Effanov, 1997). Neurotransmisision is 
mediated by protein kinase C (Effanov, 1997), modulation of calcium influx coupled with 
the inhibition of phosphatases (Larsson, 1997), and efficient messenger RNA export 
(York, 1999 and Odom, 2000). IP6 stimulates non-homologous DNA end joining of 
double strand DNA breaks by binding to the Ku70/80 subunits of DNA-dependent 
protein kinase in vitro (Hanakahi, 2002). 
 Inositol phosphates are synthesized from inositol and adults consume 
approximately 1g of inositol per day in their normal diets (Shamsuddin, 1996). Inositol 
phosphates are not just geared towards animals. Phytate, the salt of phytic acid, is widely 
distributed in the plant kingdom. It serves as a storage form of phosphorous and minerals 
and contains 75% of total phosphorous of corn kernels (Raboy, 2003). Other parts of 
plants such as roots, tubers and turions, are very low in phytate (Phillippy, 2003). Besides 
phytate, other inositol phosphates such as inositol pentaphosphates and inositol 
tertraphosphates are also present in seeds, however, to a much lower extent (Dorsch, 
2003). During the germination of seeds, phytate is hydrolysed (Tabekhia, 1980 and Beal, 
1985) and phosphate along with minerals such as calcium and magnesium becomes 
available for germination and development of the seedlings, explaining the significant 
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role of IP1-IP6. In addition to serving as the major phosphorus storage compound in 
seeds, inositol phosphates also act as natural antioxidants by chelation and reduction of 
the catalytic activities of many divalent transition metals (Verghese, 2006).  
Phytic acid is one of the bioactive compounds that are being intensively studied to 
evaluate their effects on health. The chelation ability of phytic acid with minerals has 
been suggested to have beneficial effects toward lowering serum cholesterol and 
triglycerides and suppression of iron-mediated oxidation (Lee, 2005). It has been shown 
to have potential as an anticancer agent that only affects malignant cells and not normal 
cells and tissues (Shamsuddin, 2003). A variety of benefits of phytic acid on human 
health have also been reported including its potential as anti-cancer properties in soft 
tissue, colon, prostate, and mammary cancers. It may also act as an inhibitor for renal 
stone development (Dost, 2006 and Tokul, 2006). Phytate is not easily hydrolyzed. 
Ruminants readily digest phytate because of the phytase produced by rumen 
microorganisms (Klopfenstein, 2002). This compound is not obtained directly from the 
animal diet, but is synthesized inside the cell from phosphate and inositol, that is obtained 
in the diet (Hanakahi, 2000). The interaction of intracellular phytic acid with specific 
intracellular proteins has been investigated in vitro, and these interactions have been 
found to result in the inhibition or potentiation of the physiological activities of those 
proteins which could lead to certain anti-cancerous benefits (Hanakahi, 2000 and Norris, 
1995).  
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Mucin 3 
Mucin 3 (Muc-3) is a large glycoprotein expressed by many tissues in the body 
including the stomach, intestine, gallbladder, and colon (Weiss, 1996). A sequence of 
tandem repeats in the structure can be identified through cloning and characterization of 
intestinal cDNA using a probe. There are seventeen residue threonine and serine tandem 
repeats in the domain. The gene for Muc-3 is located at position q22 (long arm) on 
chromosome seven. Muc-3 expression differs from other mucin proteins in the human 
small intestine as it is expressed in both goblet cells and enterocytes while others are 
specifically expressed in goblet cells (Gum, 1997). Muc-3 is a trans-membrane 
glycoprotein that is seen in both colorectal cancers and normal colon (Chang, 1994) with 
a 3′ terminus coding for two epithelial growth factor-like domains, a transmembrane 
domain and a cytoplasmic tail (Mack, 2003). Studies have shown an association between 
Muc-3 expression and poor prognosis in a number of cancers including pancreatic (Park, 
2003), breast (Rakha, 2005), gastric (Wang, 2003) and renal (Leroy, 2003). There is 
some evidence suggesting that Muc-3 expression is reduced in colorectal cancers and that 
this varies between histological types (Weiss, 1996). 
Mucins and cancer 
Mucins have been implicated in the pathogenesis of certain cancers such as 
adenocarcinomas and malignant tumors of the intestinal tract. It has been proposed that 
mucins act as markers for tumors to map the microenvironment during invasion and 
growth. Immunohistochemical studies have tumor-associated antigen sites on mucins. 
These sites induce a conformational change when over/under glycosylated. A decrease in 
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glycoprotein mucin in serum has shown proportional correlation to cancer growth and 
tumor burden. This leads to the suspicion that abnormal forms of mucin might lead to 
certain cancers (Hollingsworth, 2004). The relationship between IP6 and mucin 
expression has not been exhaustively shown. Experiments that demonstrated the 
anticancer feature of phytate were performed by Shamsuddin et al. (1998) and concluded 
that only diets containing high phytate content (cereals and legumes) showed a negative 
correlation with colon cancer. 
Dietary phytates occur in the digestive tract and they come in contact with mucins 
that line the digestive tract such as the transmembrane Muc-3. The consequence and role 
of such interactions is yet to be discovered. We hypothesized, in the present study, that 
the presence of phytate in the digestive tract will alter the expression of Muc-3. To test 
the hypothesis, the expression of Muc-3 in gastrointestinal tissues in the presence of 
phytates will be determined.  
  
	   11	  
Materials and Methods 
Eighteen 8-week old black-6 (C57BL/6) mice were appropriately acclimatized for 
3 days before experimentation. They were housed in cages in groups as littermates. Mice 
were then allowed to settle down in their new cages for 3 days before experimentation. 
Mice were fed a commercial regular diet. Different cages were randomly divided into 3 
groups that were assigned to the 3 different treatments (IP6 dose rates of 0, 1, and 2 g/kg 
body weight). Each treatment group consisted of 6 mice. IP6 for dosing was prepared in 
10% sucrose solution by preparing 100 mL of 80 g of IP6/100 ml solution (Na phytate 
salt was used, Sigma-Aldrich Corp., St Louis, MO, USA, Catalog # P8810) and then 
serial diluted to obtain 40 g and 20 g IP6/100 mL solutions. In order to dose a fixed 
volume of treatment material per gram of body weight different concentrations of IP6 
were used: 40 g IP6/100 mL solution was used for the 2 g IP6/kg BW dose rate; 20 g 
IP6/100 mL solution was used for the 1 g IP6/kg BW dose rate.  The same volume of 
10% sucrose solution was used for the control animals (0 g IP6/kg BW dose rate). Hence, 
for a given bodyweight, the same volume of treatment material was dosed (5 mL/kg 
BW). 
 The 3 treatment groups of mice were dosed orally with IP6 solution using gavage 
needles for 5 days. Mice were weighed once at the beginning of the experiment before 
the dosing and also on day 6 before they were euthanized by carbon dioxide 
asphyxiation. The gastrointestinal tract was dissected and divided into different sections: 
stomach, duodenum, jejunum, ileum and colon. The samples were placed in dry ice after 
collection and subsequently stored at -80 °C for later use or kept on ice for immediate 
homogenization. 
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Preparation of Lysate From Tissues After Storage 
 
To prepare the lysate, lysis buffer was added to each tube of tissue and the tissue 
homogenized with an electric homogenizer for two minutes, and centrifuged twice for 20 
minutes at 16000 x g and 4°C in a micro centrifuge. The tubes were placed in ice and the 
supernatant was transferred to another tube while discarding the pellet. Samples were 
diluted to 2 µg/mL for SDS-PAGE. 
BSA Protein Assay Technique 
A BSA protein assay was used to determine the correct concentration of protein to 
dilute for SDS-PAGE standards (2ug/mL) in conjunction with a 96 well plate. Pierce™ 
Bovine Serum Albumin Standards were used according to manufacturer instruction to 
make protein standards. The albumin standard was formulated at 2mg/mL in ultrapure 
0.9% sodium chloride (saline).  Standards are used to generate a standard curve for 
known protein concentrations at different concentrations to measure against the sample. 
The next step is to dilute proteins to a 1:1000 ratio. 25 uL of each standard (A-I) were 
added to each well in the first row of the 96 well plate. The samples were diluted 1:1000. 
The plate was then incubated in a water bath for 30 minutes. A NanoDrop 2000/2000c 
Spectrophotometer was used to determine protein concentration.1 uL sample of protein 
from each mouse was placed on the NanoDrop 2000/2000c-testing platform after setting 
a standard curve using BSA standards.  
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Gel Electrophoresis 
SDS-PAGE is a form of gel electrophoresis that can separate proteins based on 
molecular weight exclusively. SDS (Sodium Dodecyl Sulfate) is a reagent that denatures 
proteins (disrupts secondary, tertiary, and quaternary structure) and gives them a uniform 
negative charge. The proteins can migrate towards the anode of the apparatus with 
smaller proteins traveling farther. The gel was placed in casting stands making sure the 
wells face the inside of the chamber. The tank was then filled 1x chamber buffer to 
maintain pH upon separation with electrode wires attached to their correct charge. The 
volume of protein (2 ug/uL) to be loaded in the well was calculated using the dilution 
formula C1V1=C2V2 and gel was loaded after heating the proteins at 95 °C for four 
minutes. 10 uL of marker and 20 uL samples were used. The gel was run at 200V and 40 
mA for 60 minutes.  
 
Transfer of Proteins to Membrane 
To transfer the proteins to membrane, the gels were removed and placed in 
transfer buffer while assembling the gel transfer apparatus in the following order: sponge, 
filter paper, gel, membrane, filter paper, and sponge.  The order is important to ensure the 
protein gel is correctly applied to the membrane after transfer. The PVDF membrane was 
soaked in methanol before assembling. The highly hydrophobic nature of the PVDF 
membrane would inhibit transfer of the gel if methanol were forgotten. The chamber was 
filled with transfer buffer up to blocking line and an ice block was added as well as a stir 
rod before running at (200V and 350mA for 60 minutes). 
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Blotting 
The membrane was removed and gently put in a box with 5% skim milk overnight 
at 4 °C. The skim milk was made by dissolving 4.54 g of casein with 100 mL of 1x tris-
buffered saline with tween (TSBT) to maintain pH while blotting. The milk will bind to 
proteins that are not of interest. The membrane was then taken and washed 3x with 1x 
TBST for 15 minutes each. Tween, a component of TSBT, attaches to the membrane 
elsewhere than the target protein. When antibody is added, there is no place for the 
antibody to bind other than target protein, which results in fewer false positives and 
clearer results. Two vials of the primary antibody were added (8 uL) to 8mL of 5% skim 
milk. The primary antibody will bind to the epitope region of the protein. The membrane 
was stored overnight at 4°C. The membrane was then washed 3x with 1x TBST again for 
15 minutes to rid the membrane of milk before adding the secondary antibody.  
Secondary antibody was added at 6uL to 9mL milk (1ul to 1.5 mL ratio), and the 
membrane was placed in the secondary antibody solution at room temperature for one 
hour. The luminescent secondary antibody will bind to the protein-primary antibody 
complex. Once the substrate is added, a reaction occurs that fluoresces the membrane. 
The membrane was washed again 3x with 1x TBST for 15 minutes each before observed 
under chemiluminescence using Thermo Scientific™ SuperSignal™ West Femto 
Chemiluminescent Substrate Kit.  
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Chemiluminescence 
The membrane was treated with SuperSignal™ mix (substrate of reaction). This 
was accomplished by mixing 1mL of Reagent A with 1mL of Reagent B to give 1:1 ratio 
to give enough to use on one membrane. The light that is detected is a transient product 
of the reaction when the protein-antibody-enzyme substrate complex binds and the 
reaction occurs. The membrane was visualized with a Proteinsimple™ FluorChem E 
Imager under UV light. 
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Results and Discussion 
The final body weight of the mice fed with 2g/kg phytate was higher than mice 
fed with 1g/kg and 0g/kg, respectively, as shown in Table 1. The 2g/kg phytate group 
was the sole group that gained weight during the study (figures 1 and 2). This could be 
possibly due to phytate influencing the uptake of nutrients. According to Panda (2005), 
chickens that were fed a diet of non-phytate phosphorus had decreased weight compared 
to the group that had been given phytate phosphorus.  






0 g/kg group 23.1 20.0 -3.1 
1 g/kg group 22.0 20.2 -1.8 
2 g/kg group 23.4 25.0 +1.6 
Table 1: Average body weight of mice fed different levels of phytate 
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Figure 2: Average change in body weight of mice fed differing levels of phytate 
 
Expression of Muc-3 changed along the gastrointestinal tract (figure 3), which 
showed decreased levels along the length of the small intestine. The lowest expression of 
Muc-3 was found in the stomach. 
 
Figure 3: Expression of Mucin 3 along the gastrointestinal tract in control  
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Mucin 3 expression in the stomach and the intestinal sections is shown in figures 
4-7. Different doses of IP6 resulted in an increased expression of Muc-3 primarily in the 
duodenum (Table 2, Figure 4) and jejunum (Table 3, Figure 5), however, the expression 
decreased in 1g/kg stomach (Table 4, Figure 6) and ileum (Table 5, Figure 7) tissue.   
 
Table 2: Mucin 3 expression in mouse duodenum tissue 
 
 
Figure 4: Mucin 3 expression in duodenum 
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48 936 N/A 592 777 297 252 1092 660 
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Table 3:  Mucin 3 expression in mouse jejunum tissue 
 
 
Figure 5: Mucin 3 expression in jejunum 
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Area of expression 120 N/A 132 348 N/A 444 420 168 














136 122 116 132 120 52 
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420 108 272 132 396 310 546 N/A 189 
	   21	  
 
Figure 7: Ileum Mucin 3 expression 
 
The increased expression of Muc-3 in the duodenum (Figure 4) and jejunum 
(Figure 5) could be due to inositol phosphate increasing goblet cell production. 
Satchithanandam (1990) observed that when mice are fed diets supplemented with 
inositol phosphate, they had higher goblet cell activity, higher cytokine production, and 
greater incorporation of radioactive tracers. Goblet cell production also can increase 
Muc-3 production.  
There was increased expression from the 0g/kg phytate group to the 2g/kg phytate 
group in all protein Muc-3 tissue. The Muc-3 expression from the 2g/kg phytate group in 
the stomach and ileum remained the same or decreased from the control (Table 2 and 
Table 5). This could be due to IP6 interacting strongly with Muc-3 in those areas (Kufe, 
2015). A loss of mucin may confer a microenvironment in which bacteria can activate an 
inflammatory response at the epithelial surface (Kufe, 2015). A decrease in glycoprotein 
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(Hollingsworth, 2004).  A decrease in glycoprotein mucin could also lead to increased 
inflammatory/growth responses in the stomach and ileum region due to less/normal 
mucin expression in the 1g/kg and 2g/kg groups due to phytate.  
As shown in Table 6, the area of expression of Muc-3 stayed relatively the same 
in the stomach tissue.  
 
Table 6: Average expression of muc-3 in duodenum, jejunum, ileum, and stomach tissue 
 
Mucin content in the stomach is highly protected due to acidic pH in stomach. In 
fact, according to Boltin (2013), fifty percent of gastric lesions in gastric ulcer patients 
had the same mucin content as stomach tissue without lesions. Excessive ingestion of 
undegraded phytates can cause mineral deficiencies in humans (Iqbal, 1994). The ileum 
absorbs fat-soluble vitamins and minerals. A decrease of expression in the 1g/kg and 
2g/kg phytate groups compared to the control as shown in Table 5 may correlate to Muc-
3 decrease of expression due to phytate disturbing the uptake of minerals and vitamins.  
In summary, IP6-mediated expression of Muc-3 in the stomach stayed relatively 
similar. The expression of Muc-3 in the duodenum increased by an average of forty-
seven percent in the 1g/kg and 2g/kg phytate groups when compared to the control group. 
Jejunum Muc-3 expression was increased by ninety percent in both 1g/kg and 2g/kg 
Average Expression Duodenum Jejunum Ileum Stomach 
0g/kg 492 126 266 124 
1g/kg 764 240 170 123 
2g/kg 685 240 266 126 
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phytate groups. The ileum 0g/kg and 2g/kg phytate groups had the same expression of 
Muc-3, while the 1g/kg phytate group showed a thirty-six percent decrease. In 
conclusion, Muc-3 expression in the presence of IP6 did not change in the stomach, 
increased in the duodenum and jejunum, and decreased in the 1g/kg dose in the ileum. 
Hence our hypothesis that the presence of phytate in the digestive tract will alter the 
expression of Muc-3 was proven to be true in the duodenal and jejunal sections of the 
gastrointestinal tract. The effects of IP6 may be through changing the expression of Muc-
3 in the duodenum and jejunum.  
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